Safety of hormonal contraceptives among women with migraine: A systematic review



      Migraine is common among women of reproductive age and is associated with an increased risk of ischemic stroke. Combined oral contraceptives (COCs) are also associated with an increased risk of ischemic stroke. Use of hormonal contraception among women with migraine might further elevate the risk of stroke among women of reproductive age.


      To identify evidence regarding the risk of arterial thromboembolism (stroke or myocardial infarction) among women with migraine who use hormonal contraceptives.


      We searched the PubMed database for all articles published from database inception through January 2016. We included studies that examined women with migraine overall or separated by subtype (with or without aura). Hormonal contraceptives of interest included combined hormonal methods (COCs, patch and ring) and progestin-only methods (progestin-only pills, injectables, implants and progestin intrauterine devices).


      Seven articles met inclusion criteria. All were case–control studies of fair to poor quality reporting on use of COCs or oral contraceptives (OCs) not further described and all reported stroke outcomes. Four studies demonstrated that, among women with migraine (not separated by subtype), COC use was associated with approximately two to four times the risk of stroke compared with nonuse. The only study to examine specific migraine subtypes found an elevated risk of stroke among women with migraine with aura, and this risk was similar regardless of OC use, although these odds ratios were not reported. Two studies did not report risks among women with migraine and COC use combined, but both found increased risks of stroke with migraine and COC use independently. No evidence was found on other hormonal contraceptives or on risk of myocardial infarction.


      Limited evidence suggests a two- to fourfold increased risk of stroke among women with migraine who use COCs compared with nonuse. Additional study is needed on the risks of hormonal contraceptives, including combined and progestin-only methods, among women with different migraine subtypes.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Sacco S.
        • Ricci S.
        • Degan D.
        • Carolei A.
        Migraine in women: the role of hormones and their impact on vascular diseases.
        J Headache Pain. 2012; 13: 177-189
        • Headache Classification Committee of the International Headache Society
        The international classification of headache disorders, 3rd edition (beta version).
        Cephalalgia. 2013; 33: 629-808
        • Kurth T.
        • Chabriat H.
        • Bousser M.G.
        Migraine and stroke: a complex association with clinical implications.
        Lancet Neurol. 2012; 1192-100
        • Kurth T.
        The association of migraine with ischemic stroke.
        Curr Neurol Neurosci Rep. 2010; 10: 133-139
        • Xu Z.
        • Li Y.
        • Tang S.
        • Huang X.
        • Chen T.
        Current use of oral contraceptives and the risk of first-ever ischemic stroke: a meta-analysis of observational studies.
        Thromb Res. 2015; 136: 52-60
        • MacGregor E.A.
        Migraine management during menstruation and menopause.
        Continuum. 2015; 21990-1003
        • Centers for Disease Control and Prevention
        U.S. medical eligibility criteria for contraceptive use, 2010.
        MMWR Recomm Rep. 2010; 591-86
        • Curtis K.M.
        • Mohllajee A.P.
        • Peterson H.B.
        Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review.
        Contraception. 2006; 73: 189-194
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        • Group P.
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        Br Med J. 2009; 339: b2535
        • Peragallo Urrutia R.
        • Coeytaux R.R.
        • McBroom A.J.
        • Gierisch J.M.
        • Havrilesky L.J.
        • Moorman P.G.
        • et al.
        Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.
        Obstet Gynecol. 2013; 122: 380-389
        • Harris R.P.
        • Helfand M.
        • Woolf S.H.
        • Lohr K.N.
        • Mulrow C.D.
        • Teutsch S.M.
        • et al.
        Current methods of the US preventive services task force: a review of the process.
        Am J Prev Med. 2001; 20: 21-35
        • Oral contraceptives and stroke in young women
        Associated risk factors.
        J Am Med Assoc. 1975; 231: 718-722
        • Chang C.L.
        • Donaghy M.
        • Poulter N.
        Migraine and stroke in young women: case–control study. The World Health Organisation collaborative study of cardiovascular disease and steroid hormone contraception.
        Br Med J. 1999; 318: 13-18
        • Lidegaard O.
        Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease.
        Br J Obstet Gynaecol. 1995; 102: 153-159
        • MacClellan L.R.
        • Giles W.
        • Cole J.
        • Wozniak M.
        • Stern B.
        • Mitchell B.D.
        • et al.
        Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study.
        Stroke. 2007; 38: 2438-2445
        • Nightingale A.L.
        • Farmer R.D.
        Ischemic stroke in young women: a nested case–control study using the UK general practice research database.
        Stroke. 2004; 35: 1574-1578
        • Schwartz S.M.
        • Petitti D.B.
        • Siscovick D.S.
        • Longstreth Jr., W.T.
        • Sidney S.
        • Raghunathan T.E.
        • et al.
        Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies.
        Stroke. 1998; 29: 2277-2284
        • Tzourio C.
        • Tehindrazanarivelo A.
        • Iglesias S.
        • Alperovitch A.
        • Chedru F.
        • d'Anglejan-Chatillon J.
        • et al.
        Case–control study of migraine and risk of ischaemic stroke in young women.
        Br Med J. 1995; 310: 830-833
        • Gillum L.A.
        • Mamidipudi S.K.
        • Johnston S.C.
        Ischemic stroke risk with oral contraceptives: a meta-analysis.
        J Am Med Assoc. 2000; 284: 72-78
        • Etminan M.
        • Takkouche B.
        • Isorna F.C.
        • Samii A.
        Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies.
        Br Med J. 2005; 330: 63
        • Schurks M.
        • Rist P.M.
        • Bigal M.E.
        • Buring J.E.
        • Lipton R.B.
        • Kurth T.
        Migraine and cardiovascular disease: systematic review and meta-analysis.
        Br Med J. 2009; 339: b3914
        • Spector J.T.
        • Kahn S.R.
        • Jones M.R.
        • Jayakumar M.
        • Dalal D.
        • Nazarian S.
        Migraine headache and ischemic stroke risk: an updated meta-analysis.
        Am J Med. 2010; 123: 612-624
        • Guidetti D.
        • Rota E.
        • Morelli N.
        • Immovilli P.
        Migraine and stroke: “vascular” comorbidity.
        Front Neurol. 2014; 5193
        • Carolei A.
        • Marini C.
        • De Matteis G.
        History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council study group on stroke in the young.
        Lancet. 1996; 347: 1503-1506
        • Lidegaard O.
        • Lokkegaard E.
        • Jensen A.
        • Skovlund C.W.
        • Keiding N.
        Thrombotic stroke and myocardial infarction with hormonal contraception.
        N Engl J Med. 2012; 366: 2257-2266
        • Calhoun A.
        Combined hormonal contraceptives: is it time to reassess their role in migraine?.
        Headache. 2012; 52: 648-660
      1. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives.
        in: Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. 57. 1998: 315-324
        • Heinemann L.A.
        • Assmann A.
        • DoMinh T.
        • Garbe E.
        Oral progestogen-only contraceptives and cardiovascular risk: results from the transnational study on oral contraceptives and the health of young women.
        Eur J Contracept Reprod Health Care. 1999; 4: 67-73
        • Lidegaard O.
        Oral contraception and risk of a cerebral thromboembolic attack: results of a case–control study.
        Br Med J. 1993; 306: 956-963
        • Lidegaard O.
        • Kreiner S.
        Contraceptives and cerebral thrombosis: a five-year national case–control study.
        Contraception. 2002; 65: 197-205
        • Petitti D.B.
        • Siscovick D.S.
        • Sidney S.
        • Schwartz S.M.
        • Quesenberry C.P.
        • Psaty B.M.
        • et al.
        Norplant implants and cardiovascular disease.
        Contraception. 1998; 57: 361-362
        • Goldstein L.B.
        • Bushnell C.D.
        • Adams R.J.
        • Appel L.J.
        • Braun L.T.
        • Chaturvedi S.
        • et al.
        Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2011; 42: 517-584
        • Sacco S.
        • Ornello R.
        • Ripa P.
        • Pistoia F.
        • Carolei A.
        Migraine and hemorrhagic stroke: a meta-analysis.
        Stroke. 2013; 44: 3032-3038
        • Donaghy M.
        • Chang C.L.
        • Poulter N.
        Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age.
        J Neurol Neurosurg Psychiatry. 2002; 73: 747-750
        • Kurth T.
        • Schurks M.
        • Logroscino G.
        • Buring J.E.
        Migraine frequency and risk of cardiovascular disease in women.
        Neurology. 2009; 73: 581-588
        • Meschia J.F.
        • Bushnell C.
        • Boden-Albala B.
        • Braun L.T.
        • Bravata D.M.
        • Chaturvedi S.
        • et al.
        Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2014; 45: 3754-3832
        • Bushnell C.
        • McCullough L.D.
        • Awad I.A.
        • Chireau M.V.
        • Fedder W.N.
        • Furie K.L.
        • et al.
        Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2014; 45: 1545-1588
        • Oral contraception and increased risk of cerebral ischemia or thrombosis
        Collaborative group for the study of stroke in young women.
        N Engl J Med. 1973; 288: 871-878